You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 13, 2025

Patent: 10,787,507


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,787,507
Title:Antagonists of IL-6 to prevent or treat thrombosis
Abstract: The present invention is directed to therapeutic methods using IL-6 antagonists such as antibodies and fragments thereof having binding specificity for IL-6 to prevent or treat thrombosis in diseases associated with abnormal blood coagulation or fibrinolysis. In preferred embodiments these patients will comprise those exhibiting elevated D-dimer or other cogulation cascade related proteins and optionally will further exhibit elevated C reactive protein prior to treatment. The subject therapies also may include the administration of other actives such as chemotherapeutics, anti-coagulants, statins, et al.
Inventor(s): Smith; Jeffrey T. L. (Dublin, GB)
Assignee: VITAERIS INC. (Vancouver, BC, unknown)
Application Number:15/902,041
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 10,787,507

Introduction

Understanding the claims and the broader patent landscape of a specific patent is crucial for inventors, patent attorneys, and business professionals. This analysis will delve into the details of United States Patent 10,787,507, focusing on its claims, the legal and procedural context, and the implications within the patent landscape.

Overview of the Patent

United States Patent 10,787,507, though not directly provided in the sources, can be analyzed using general principles of patent law and drafting.

Patent Claims: Structure and Significance

Types of Claims

Patent claims are the heart of any patent application, defining the scope of the invention. There are several types of claims, including product claims, process claims, and product-by-process claims[4].

  • Product Claims: These define the physical characteristics of the invention.
  • Process Claims: These describe the method or steps involved in the invention.
  • Product-by-Process Claims: These define a product by the process used to make it.

Claim Format and Requirements

Claims must adhere to specific formats and requirements. They should be clear, concise, and supported by the description in the patent application. Here are some key aspects:

  • Independent and Dependent Claims: Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims[4].
  • Clarity and Word Choice: Claims must avoid ambiguity and inconsistency. Terms should be defined clearly, and relative terms should be used judiciously[4].
  • Overcoming Prior Art: Claims must distinguish the invention from prior art to be patentable[4].

Legal and Procedural Context

Patent Application Process

A nonprovisional patent application, like the one for US 10,787,507, must include several components:

  • Claims: Define the invention.
  • Abstract: A brief summary of the invention.
  • Description: A detailed description of the invention.
  • Oath or Declaration: A statement from the inventor.
  • Drawings: Visual representations of the invention, if necessary[4].

Patent Office Procedures

The United States Patent and Trademark Office (PTO) examines patent applications to ensure they meet the requirements for patentability, including novelty, inventive step, and industrial application.

  • Restriction Requirements: The PTO may issue restriction requirements if an application includes multiple independent and distinct inventions[2].
  • Terminal Disclaimers: Applicants must disclaim any term in a subsequent patent application that would extend the term of an already-issued patent to avoid obvious double patenting[3].

Historical and Administrative Context

History of the Patent Office

The Patent Office, now known as the Patent and Trademark Office, has a rich history dating back to the Patent Act of 1790. It has undergone several reorganizations and has been part of different departments, including the Department of State, the Department of the Interior, and currently the Department of Commerce[1].

Record Keeping and Documentation

Historical records of patents, including those reconstructed after the 1836 fire, are crucial for understanding the evolution of patent law and practice. These records include textual descriptions, engineering plans, and microfilm publications[1].

Patent Term and Adjustments

Patent Term Adjustment (PTA)

The PTA compensates applicants for delays caused by the Patent Office during prosecution, extending the patent term up to three years. However, this can raise issues of obvious double patenting if not managed properly[3].

Impact of URAA

The Uruguay Round Agreements Act (URAA) changed the patent term to be tied to the effective filing date, affecting transitional applications and leading to a surge in filings known as the "GATT Bubble"[2].

Critical Analysis of Patent Claims

Broad and Narrow Claims

Effective patent drafting involves a balance between broad and narrow claims. Broad claims provide wider protection but risk being invalidated if they are too broad, while narrow claims are more specific but offer narrower protection[4].

Avoiding Unnecessary Limitations

Claims should avoid unnecessary limitations to maintain the broadest possible scope of protection. However, they must also be clear and supported by the description to avoid rejection or invalidation[4].

Negative Limitations and Disclaimers

Negative limitations and disclaimers can be used to clarify the scope of the invention and avoid conflicts with prior art or other patents. However, these must be used carefully to avoid inadvertently narrowing the scope of protection[4].

Case Studies and Industry Insights

Hyatt v. United States Patent and Trademark Office

This case highlights the complexities of restriction requirements and the need for careful claim drafting to avoid issues during examination. The case involved a restriction requirement for multiple claims, emphasizing the importance of managing claim scope and distinct inventions[2].

Cellect Case

The Cellect case underscores the importance of terminal disclaimers and the avoidance of obvious double patenting. It shows how delays in prosecution can impact patent term adjustments and the need for careful management of multiple patent applications[3].

Key Takeaways

  • Clear and Concise Claims: Ensure claims are clear, concise, and supported by the description.
  • Avoid Unnecessary Limitations: Minimize unnecessary limitations to maintain broad protection.
  • Manage Multiple Inventions: Carefully handle multiple independent and distinct inventions to avoid restriction requirements.
  • Understand Patent Term Adjustments: Be aware of PTA and its implications on patent term to avoid issues of obvious double patenting.
  • Historical Context: Understand the historical and administrative context of patent law to better navigate current practices.

Frequently Asked Questions (FAQs)

What are the key components of a nonprovisional patent application?

A nonprovisional patent application must include claims, an abstract, a description, an oath or declaration, and drawings if necessary[4].

How does the PTO handle multiple independent and distinct inventions in a single application?

The PTO may issue a restriction requirement if an application includes multiple independent and distinct inventions, requiring the applicant to select which claims to pursue first[2].

What is the purpose of a terminal disclaimer in patent law?

A terminal disclaimer is used to disclaim any term in a subsequent patent application that would extend the term of an already-issued patent, avoiding obvious double patenting[3].

How has the URAA impacted patent filings and terms?

The URAA changed the patent term to be tied to the effective filing date, leading to a surge in filings known as the "GATT Bubble" and affecting transitional applications[2].

What are the consequences of failing to overcome prior art in patent claims?

Claims that do not distinguish the invention from prior art risk being rejected or invalidated. Ensuring that claims overcome prior art is crucial for securing patent protection[4].

Cited Sources

  1. Records of the Patent and Trademark Office - National Archives
  2. Hyatt v. United States Patent and Trademark Office - U.S. Court of Appeals for the Federal Circuit
  3. Federal Circuit Puts the Onus on Patent Owners to Disclaim - Mintz
  4. WIPO Patent Drafting Manual: Second Edition - World Intellectual Property Organization

More… ↓

⤷  Subscribe

Details for Patent 10,787,507

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Bausch Health Us, Llc IPRIVASK desirudin For Injection 021271 April 04, 2003 ⤷  Subscribe 2027-05-21
Janssen Biotech, Inc. REOPRO abciximab Injection 103575 December 22, 1994 ⤷  Subscribe 2027-05-21
Genentech, Inc. RITUXAN rituximab Injection 103705 November 26, 1997 ⤷  Subscribe 2027-05-21
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 September 25, 1998 ⤷  Subscribe 2027-05-21
Genentech, Inc. HERCEPTIN trastuzumab For Injection 103792 February 10, 2017 ⤷  Subscribe 2027-05-21
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.